Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10047559 | 0.93 | CYP19A1 (0.36) | CYP19A1 | |
| SCHEMBL4567206 | 0.90 | CYP19A1 (0.34) | CYP19A1PRKCA | |
| SCHEMBL17068925 | 0.90 | PRKCA (0.33) | CYP19A1PRKCA | |
| SCHEMBL17068924 | 0.88 | PRKCA (0.34) | CYP19A1PRKCA | |
| SCHEMBL20299549 | 0.79 | CYP19A1 (0.36) | CYP19A1PRKCA | |
| SCHEMBL4567207 | 0.79 | CYP19A1 (0.36) | CYP19A1PRKCA | |
| SCHEMBL13147621 | 0.78 | CYP19A1 (0.40) | CYP19A1 | |
| SCHEMBL21974553 | 0.78 | CYP19A1 (0.40) | CYP19A1 | |
| SCHEMBL22205224 | 0.78 | CYP19A1 (0.40) | CYP19A1 | |
| SCHEMBL22205226 | 0.78 | CYP19A1 (0.40) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180195096-A1 | Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives | UNIV OXFORD INNOVATION LTD (GB) | 2018-07-12 | — | — | US | disclosed |
| US-20170196827-A1 | Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation | TDELTAS (GB) | 2017-07-13 | — | — | US | disclosed |
| US-9579302-B2 | Ketone bodies to protect tissues from damage by ionizing radiation | TDELTAS (GB) | 2017-02-28 | — | — | US | disclosed |
| US-20150250755-A1 | KETONE BODIES TO PROTECT TISSUES FROM DAMAGE BY IONIZING RADIATION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2015-09-10 | — | — | US | disclosed |
| US-20120122978-A1 | Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment | ACCERA, INC. (US) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250755-A1 | KETONE BODIES TO PROTECT TISSUES FROM DAMAGE BY IONIZING RADIATION | ACACB, BCKDK, ACACA | CYP19A1 913/4885PRKCA 77/4885 |
| US-20170196827-A1 | Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation | ACACB, BCKDK, ACACA | CYP19A1 913/4885PRKCA 77/4885 |
| US-20180195096-A1 | Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives | BCHE, LIPC, ACACB | CYP19A1 386/4885PRKCA 932/4885 |
| US-20120122978-A1 | Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment | CPT1B, ACADM, ACAA2 | CYP19A1 2006/4885PRKCA 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.